The Future of the Connected Lab: Features vs. Integration Full Interview with Eva-Lotta Westberg and Michael Elliott
We respect your privacy, by submitting this form you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest. For further information on how we process and monitor your personal data click here.
In this exclusive Pharma IQ Interview Michael Elliott, CEO, Atrium Research and Eva-Lotta Westberg, Program Manager, AstraZeneca, discuss what vendors could be doing better to support interoperability, features vs. integration and the biggest challenges for an integration project. Westberg also shares key lessons learnt from embarking on an integration project and her future insights for the connected lab.